Investorideas.com - Cannabis Stock News: City View Green Holdings (CSE: CVGR) (OTCQB: CVGRF) and Budd Hutt Inc. Announce Approval of One Retail Cannabis Store License & Three Pending Final Inspections in Alberta: Strategic Investment from Quinsam Capital in Budd Hutt Totals $2.2M
www.investorideas.com - news that inspires big ideas
Monday, 15 June 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 428 (NASDAQ: $NEPT) (TSX: $NEPT.TO) (TSX: $TGOD.TO) (NASDAQ: $GNLN) (OTC: $PSYC)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 428 (NASDAQ: $NEPT)
(TSX: $NEPT.TO) (TSX: $TGOD.TO)
(NASDAQ: $GNLN) (OTC: $PSYC)
Delta, Kelowna, BC, June 15, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at http://www.investorideas.com/news/2020/cannabis-potcasts/06151NEPT-TGOD-GNLN-PSYC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Neptune
Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated
health and wellness company, announce today that the Company's Health &
Wellness Innovations division has launched Neptune Halo, an electronic pulse
oximeter device that is a key tool in the battle against COVID-19.
According to the American Lung
Association, the pulse oximeter observes a rapid measurement of oxygen
saturation level in the body without using needles or taking a blood sample,
which alerts users to seek medical help if their oxygen levels are too low.
In an April 24th, New York Times article, Dr. Richard
Levitan, an emergency physician in Littleton, N.H, commented: "Patients
with COVID-19 can experience a potentially dangerous drop in oxygen saturation
without having obvious breathing problems. Without a pulse oximeter, they might
never know it or get very used to how they feel, despite very low oxygen
levels. By the time they go to the hospital feeling shortness of breath, their
oxygen levels would have dropped significantly, and they could have very
advanced COVID pneumonia."
Neptune Health & Wellness
Innovations is rapidly bringing new products to market to address market demand
for critical health and wellness products such as Neptune Halo oximeter, the
Neptune Air non-contact thermometer, as well as hand sanitizer products and
other innovations in development. The
Company is preparing a B2B and B2C strategy to bring Neptune Halo and Neptune
Air to market via partnerships with national retailers and direct-to-consumers
through its own e-commerce platform and e-commerce partners.
"Neptune Halo is another
example of Neptune's ability to rapidly respond to market needs and deliver
high quality products at value pricing as a diversified and fully integrated
health and wellness company," said Michael Cammarata, Chief Executive Officer
of Neptune Wellness Solutions. "We
are proud to do our part to help people better monitor their health and
identify when a COVID infection is reducing oxygen levels."
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), a leading producer of premium
certified organic cannabis, announced that it has expanded its exclusive
licensing agreement with Colorado-based Stillwater Brands, it will be rolling
out the powerful RIPPLE suite of products in Canada, including RIPPLE Gummies
and RIPPLE QuickSticks.
Leveraging
Stillwater's proprietary technology, TGOD launched its first Cannabis 2.0
product at the end of March – TGOD Infuser 10mg THC – which quickly became one
of the top selling SKUs within the beverage category across the country. Given the success of this first product, TGOD
has decided to expand the series by introducing additional formats. Moving
forward, all formats will fall under the well-established RIPPLE brand name.
RIPPLE
products have made a name for themselves in the United States, garnering
multiple awards since their launch in 2016, including:
● The Dope
Cup (Best
Drink) – 2017
● Leafly (Best Overall
Product) – 2018
● LeafLink (Best Selling
Edible) – 2019
All
three RIPPLE dissolvables are currently in the Top 10 most-sold cannabis
beverages in Colorado, including the number one spot for RIPPLE Pure 10.
"Soluble
cannabinoids are the future of functional foods," commented Justin Singer,
CEO of Stillwater Brands. "Similar to what we saw in Colorado, the
Canadian market was overrun by inconsistent, low-quality products early on.
Novelty can only carry a product so far. Ultimately, consistency and
predictability are what keep consumers coming back. The success of RIPPLE in
Colorado proves the value of our commitment to quality above all, and TGOD's
commitment to organic, high-quality products makes them an ideal partner to
carry our vision beyond the U.S."
On their
own, ingested cannabinoids such as THC are poorly absorbed by the body. It can
take hours to feel the effects of edibles that rely on butter- or
tincture-based formulations, a situation that too often leads to
disappointment. In contrast, RIPPLE
relies on proprietary solubilization technology to render THC and CBD
water-soluble, allowing these cannabinoids to enter the bloodstream and are
proven to begin generating effects within 15 minutes of ingestion. RIPPLE's
unique chemistry and best-in-class production controls lead to products that
are fast-acting, consistent, and reliable — in other words, exactly what
consumers have been waiting for.
"We
are thrilled to leverage the strength of RIPPLE's intellectual property here in
Canada. Not only are we adding their
chewables and QuickSticks to our portfolio, we are also harnessing the power of
their proprietary technology in other products such as our teas," said
Brian Athaide, CEO of TGOD. "RIPPLE
provides novel and proven effective dose-controlled delivery methods that are
faster-acting, more standardized, and more discreet than most products
currently on the market. Consumers have quickly adopted them, and that's the
best recognition we can get as a new CPG company," added Athaide.
Greenlane
Holdings, Inc. (NASDAQ: GNLN), one of the largest global
sellers of premium cannabis accessories, child-resistant packaging, and
specialty vaporization products, today unveiled G-Verify, a consumer-facing,
scannable verification program that allows brands to communicate product
information directly to consumers. Powered by Lucid Green’s Lucid ID platform,
G-Verify can be used by brands to confirm product authenticity, share
manufacturing certifications, child-resistant compliance details, reviews,
dosage, and educational content through unique QR codes.
G-Verify harnesses the power of
Lucid Green’s 36,000 registered users and up to 600 daily scans per brand to
provide reliable product, safety, and educational information directly to
consumers and retailers. Each G-Verify Lucid ID is conveniently printed on product
packaging and can be easily scanned with any smartphone camera. Greenlane’s
latest offering in partnership with Lucid Green assures consumers that every
aspect of their favorite products, from the packaging to the hardware or
cannabis itself, is verified and compliant, and provides critical information
regarding lab testing and safety.
BRANDS
Greenlane brands that opt into
G-Verify will have direct-to-consumer control over their own brand narrative.
Each G-Verify brand landing page provides real-time updates regarding product
information, compliance testing results, marketing assets, and brand messaging.
G-Verify Lucid ID codes seamlessly integrate into existing compliance labeling
machinery and easily prints directly within existing compliance labels. In
addition, brands will receive monthly consumer data reports that can be
leveraged to update marketing content and drive sales. Most importantly,
G-Verify proactively verifies that a product is authentic, protecting brands
from intellectual property theft.
DISPENSARIES
G-Verify acts as a virtual brand
ambassador that can be easily utilized by budtenders to provide product
expertise at point-of-sale. In addition to enhancing in-store customer
experiences, G-Verify provides comprehensive employee training and guidelines
regarding best practices and ongoing product education. G-Verify brands
seamlessly integrate with existing retailer POS systems, which allows retailers
to verify product authenticity, certifications, and compliance, and even review
product testing results in real-time. Upon registration, retailers will gain
access to brand marketing assets which can be used to drive sales and customer
engagement.
CONSUMERS
Any consumer with a smartphone can
access critical product information including dosage recommendations, reviews,
ingredient breakdowns, batch information, and certifications. Consumers can
even track their personal experience with products without downloading
additional applications. G-Verify’s landing page also allows consumers to
explore verified customer reviews, industry articles, and related blogs about
participating products or brands. Unlike other compliance solutions, the
G-Verify platform also acts as a digital wallet that tracks purchases and rewards
points, allowing consumers to redeem exclusive gifts and offers.
“The legal cannabis retail
environment is still challenging space for consumers, brands, and dispensaries
to navigate,” said Aaron LoCascio, Co-Founder and CEO of Greenlane. “The
illicit market is actively competing with legal companies for customers, which
is a serious threat to consumer safety. G-Verify’s partnership with Lucid Green
delivers a vital platform that allows cannabis enthusiasts to buy and sell
consumption products with peace of mind.”
Global
Trac Solutions, Inc. (OTC: PSYC) announced that Psychedelic Spotlight has
distributed to its subscribers the first edition of its Micro-Dose Monthly
newsletter as part of the Company’s next step in developing its platform as a
leading communications channel for the emerging industry of medicinal
psychedelics. The newsletter is the culmination of the company’s insights to
introduce the important work being done within the psychedelic space.
Not only are psychedelics showing
promise as FDA-designated “breakthrough therapies,” but they may also be key to
expanding consciousness through scientific discoveries on how these substances
interact with the brain, and now, the accelerated progress of these studies
have just created unprecedented investment opportunities with the industry’s
leading companies going public this year. Psychedelics is providing hope for
millions with the potential to treat mental health disorders.
The Micro-Dose Monthly newsletter,
written by Kent Sligh of PSYC, will provide thoughts on three sections of the
industry, which are medicinal progress, lifestyle/entertainment, and investing
opportunities.
“Psychedelic medicine and the
opportunities to invest in these emerging therapies are all new to me, and it’s
exciting to get a chance to learn and write about such complex and vital
subjects,” said Kent Sligh. “After thousands of years as medicinal and
spiritual tools used in various cultures, to its mid-20th century
discovery by western scientists, followed by criminalized classification and
decades-long scientific abandonment, psychedelics as medicine are finally
experiencing transformative and historic progress while creating a dynamic new
industry in the process. I believe, PSYC recognizes this as its binding message
in developing its original content and platform as a reliable and intriguing
source that attracts readers and contributors, alike.”
“At a time when our world needs hope
and healing like never before, I believe that the newsletter strikes the right
tone and balance between application and entertainment to introduce our
subscribers to the re-emergence of psychedelics as a global therapeutic,” said
Jason LeBlanc, Global Business Consultant. “We look forward to seeing where
this journey takes us.”
The Company encourages those who are
interested in receiving the newsletter, and those who wish to stay current with
the latest insights on trends and growth associated with medicinal
psychedelics, to subscribe at the Psychedelic
Spotlight homepage.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an
endorsement to buy products or services or securities. Investors are reminded
all investment involves risk and possible loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each company
directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
Friday, 12 June 2020
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...